ficusin has been researched along with Colitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, S; Fang, C; Hu, J; Liu, X; Mei, Q; Mei, Y; Xu, J | 1 |
1 other study(ies) available for ficusin and Colitis
| Article | Year |
|---|---|
PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Colitis; Colon; Dextran Sulfate; Ficusin; Inflammasomes; Kv1.3 Potassium Channel; Macrophages; Male; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium Channel Blockers; Signal Transduction | 2019 |